血凝四项对肝硬化患者诊治的应用价值

Application Value of Four Items of Blood Coagulation in the Diagnosis and Treatment of Cirrhosis

目的探究肝硬化患者进行血凝四项检测对其临床诊治的应用价值。方法纳入2016-2017年本院收治的肝硬化患者80例,设为目标组,另纳入同时期在本院接受体检且身体健康对象80例,设为健康组。两组对象均接受血凝四项检查,归纳对肝硬化患者诊断血凝四项[PT(凝血酶原时间)、ATPP(活血部分凝血活酶时间)、TT(凝血酶时间)、FIB(纤维蛋白原)]的临床意义。结果目标组凝血四项指标与健康组存在显著差异(P<0.05)。结论医生可通过对肝硬化患者凝血四项检查指标掌握其凝血功能情况,密切监测病情发展程度,掌握是否存在出血并发症,调整治疗方案并指导其合理用药,具有突出的临床指导价值。

Objective To investigate the clinical value of four blood coagulation tests in patients with cirrhosis. Methods 80 patients with cirrhosis in our hospital from 2016 to-2017 were selected as target group, and 80 patients with physical health in the same period were selected as healthy group. The two groups received four blood coagulation tests, to sum up the diagnosis of blood coagulation of four patients with liver cirrhosis and [PT(prothrombin time), ATPP(blood partial thromboplastin time), TT(prothrombin time), FIB(fibrinogen) clinical significance. Results There were significant differences between the four indexes of blood coagulation in the target group and that in the healthy group(P<0.05). Conclusion The doctor can be used to check four indexes of blood coagulation in patients with liver cirrhosis to grasp its coagulation function, closely monitoring the disease degree of development, grasp the existence of bleeding complications, adjust the treatment plan and guide the rational use of drugs, has obvious clinical value.